Synthetic contrast breast MRI for cancer detection
Part of Cancer, Skin clinical trials.
This study tests a new way to read breast MRI images without using a contrast dye. It aims to see if this method can accurately find breast cancer and reduce the need for injections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Had a complete breast MRI scan
- No cancer diagnosis, but negative biopsy or normal follow-up for at least 12 months
- Or have breast cancer with a confirmed biopsy
- Full medical records including imaging and pathology reports available
- No prior surgery or biopsy on the affected breast before the MRI
- No breast implants on the affected side
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses existing breast ultrasound images to test how well artificial intelligence (AI) can interpret them. It may help improve future breast cancer detection tools.
This study uses artificial intelligence to look at chest CT scans taken during routine health check-ups to find early signs of breast cancer. It may help improve early detection without extra scans.
This trial uses AI to analyze your pre-treatment MRI and predict how well your tumor will respond to chemotherapy before surgery. It is for people with HR+/HER2- breast cancer who need chemo before their operation.
This study tests an AI tool that reads non-contrast breast MRI images to help find breast cancer earlier, especially in women who can't have contrast dye. You don't get extra scans — the AI reviews your existing MRI and checks its accuracy against your medical outcome.
This study tests a new, shorter breast MRI that does not require a contrast dye to see if it works as well as the standard MRI for evaluating newly diagnosed breast cancer. It could mean fewer side effects and a quicker scan for patients.
This study tests a new artificial intelligence software called Kenko Breast AI+ that analyzes breast MRI scans to help doctors better detect and monitor breast cancer. If you've had or are planning to have a breast MRI for cancer concerns, this trial might be right for you.
Hear when a new Breast Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.